Binding to plasma lipoproteins of chlorophenoxyisobutyric, tibric and nicotinic acids and their esters.
作者信息
Beaumont J L, Dachet C
出版信息
Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):41-3. doi: 10.1177/00359157760690S210.
Abstract
摘要
相似文献
1
Binding to plasma lipoproteins of chlorophenoxyisobutyric, tibric and nicotinic acids and their esters.氯苯氧基异丁酸、噻克酸和烟酸及其酯类与血浆脂蛋白的结合。
Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):41-3. doi: 10.1177/00359157760690S210.
2
Binding to plasma lipoproteins of chlorophenoxyisobutyric, tibric and nicotinic acids and their esters: its significance for the mechanism of lipid lowering by clofibrate and related drugs.
Atherosclerosis. 1976 Nov-Dec;25(2-3):255-66. doi: 10.1016/0021-9150(76)90032-0.
3
4
[Serum gas chromatographic determination of hypolipemic agents derived from clofibric acid].[血清气相色谱法测定氯贝酸衍生的降血脂药物]
Therapie. 1976 Sep-Oct;31(5):631-6.
5
[Gas chromatographic analysis of p-chlorphenoxy-isobutyric acid (clofibrate)].对氯苯氧异丁酸（安妥明）的气相色谱分析
Arzneimittelforschung. 1974 Apr;24(4):576-8.
6
7
The primary hyperlipoproteinemias.原发性高脂血症。
J Ky Med Assoc. 1974 Dec;72(12):658-62.
8
Pharmacokinetics and hypolipidemic activity of clofibrate-nicotinic acid combinations in rats.氯贝丁酯-烟酸组合在大鼠体内的药代动力学及降血脂活性
Biochem Pharmacol. 1979 Apr 1;28(7):1163-7. doi: 10.1016/0006-2952(79)90323-x.
9
10
[Serum lipoproteins and antilipemic drugs related to clofibrate. Their in vitro interaction].
Atherosclerosis. 1973 May-Jun;17(3):419-33. doi: 10.1016/0021-9150(73)90032-4.
Zotero 插件